| Literature DB >> 34259912 |
Constantin Lapa1, Ursula Nestle2,3,4, Nathalie L Albert5, Christian Baues6, Ambros Beer7, Andreas Buck8, Volker Budach9, Rebecca Bütof10,11, Stephanie E Combs12,13,14, Thorsten Derlin15, Matthias Eiber16, Wolfgang P Fendler17, Christian Furth18, Cihan Gani19,20, Eleni Gkika2, Anca-L Grosu2,3, Christoph Henkenberens21, Harun Ilhan5, Steffen Löck10,11, Simone Marnitz-Schulze6, Matthias Miederer22, Michael Mix23, Nils H Nicolay2,3, Maximilian Niyazi5,12, Christoph Pöttgen24, Claus M Rödel25,26, Imke Schatka18, Sarah M Schwarzenboeck27, Andrei S Todica5, Wolfgang Weber16, Simone Wegen6, Thomas Wiegel28, Constantinos Zamboglou2,3, Daniel Zips19,20, Klaus Zöphel11,29,30,31,32, Sebastian Zschaeck33, Daniela Thorwarth19,34, Esther G C Troost35,36,37,38,39.
Abstract
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.Entities:
Keywords: Functional imaging; PET; Radiation oncology; Radiomics
Mesh：
Year: 2021 PMID： 34259912 DOI： 10.1007/s00066-021-01812-2
Source DB: PubMed Journal: Strahlenther Onkol ISSN： 0179-7158 Impact factor: 3.621